Press Enter to search · ESC to close

Regulation Macro

FDA Halts National Priority Review Voucher Program: Report

The US Food and Drug Administration has terminated a fast-track drug review program launched in June 2025. FDA leadership told those involved that the National Priority Review Voucher Program will not proceed, though applications remain open and would not advance through the process. HHS spokesperson Emily Hilliard said the pilot is still underway and the FDA is reviewing feedback from a June public hearing to refine its framework.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback